-
Seer board urges votes against activist nominees ahead of July meeting
-
Canaccord Reiterates Buy Rating on Seer Inc. (SEER)
-
Seer files investor presentation ahead of July 28 annual meeting
-
Seer, Inc. (SEER) 30-day option implied volatility into share price up before the bell
-
Seer, Inc. (SEER) 30-day option implied volatility into share price up before the bell
-
Seer receives buyout proposal from its own CEO at $2.45 per share
-
Seer wins EU patent case, ITC probes Nanomics over IP claims
-
Radoff-JEC Group pushes for board change at Seer, Inc.
-
Radoff-JEC Group pushes for board seats at Seer amid proxy fight
-
Seer and Korea University share early cancer screening proteomics data
-
Radoff-JEC Group seeks board changes at Seer amid 97% share decline
-
Seer board urges shareholders to reject activist nominees at July meeting
-
Seer files patent complaint against Nanomics at trade commission
-
Radoff-JEC Group files proxy statement to elect directors at SEER
-
Seer board rejects revised $2.40 per share buyout offer from Radoff-JEC
-
Canaccord Reiterates Buy Rating on Seer Inc. (SEER)
-
Seer, Inc. (SEER) Tops Q1 EPS by 5c
-
Canaccord Starts Seer Inc. (SEER) at Buy
-
Seer board rejects $2.35 per share buyout offer from Radoff-JEC group
-
Seer receives $2.25 per share acquisition proposal from Radoff-JEC Group
-
PreOmics and Biognosys win US patent challenge against Seer patent
-
SEER wins patent challenge from Bruker subsidiaries
-
Radoff-JEC group calls for SEER sale amid governance concerns
-
Seer, Inc. (SEER) Tops Q4 EPS by 2c
-
The Radoff-JEC Group Issues Open Letter to Seer Inc.’s Board Concerning Immediate Need for Significant Change
-
Seer showcases proteomics technology at US HUPO conference
-
SEER study published in Nature Genetics validates protein analysis platform
-
Seer, Inc. (SEER) Misses Q3 EPS by 1c
-
Seer to present proteomics research at genetics conference
-
Seer, Inc. (SEER) Tops Q2 EPS by 3c
-
Seer, Inc. (SEER) Launches New Proteograph Workflow
-
Seer, Inc. (SEER) Tops Q1 EPS by 3c
-
TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
-
Seer, Inc. (SEER) Reports In-Line Q4 EPS
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Seer, Inc. (SEER) Misses Q3 EPS by 4c
-
Seer, Inc. (SEER) Appoints Nicolas Roelofs to its Board
-
Seer, Inc. (SEER) Announces Resignation of Chief Legal Officer
-
Seer (SEER) Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discover

